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Risk Proﬁles for Aortic Dissection and Ruptured or Surgically Treated
Aneurysms: A Prospective Cohort Study
Maya Landenhed, MD; Gunnar Engstr€om, MD, PhD; Anders Gotts€ater, MD, PhD; Michael P. Caulﬁeld, PhD; Bo Hedblad, MD, PhD;
Christopher Newton-Cheh, MD, MPH; Olle Melander, MD, PhD; J. Gustav Smith, MD, PhD
Background-—Community screening to guide preventive interventions for acute aortic disease has been recommended in high-risk
individuals. We sought to prospectively assess risk factors in the general population for aortic dissection (AD) and severe
aneurysmal disease in the thoracic and abdominal aorta.
Methods and Results-—We studied the incidence of AD and ruptured or surgically treated aneurysms in the abdominal (AAA) or
thoracic aorta (TAA) in 30 412 individuals without diagnosis of aortic disease at baseline from a contemporary, prospective cohort
of middle-aged individuals, the Malm€o Diet and Cancer study. During up to 20 years of follow-up (median 16 years), the incidence
rate per 100 000 patient-years at risk was 15 (95% CI 11.7 to 18.9) for AD, 27 (95% CI 22.5 to 32.1) for AAA, and 9 (95% CI 6.8 to
12.6) for TAA. The acute and in-hospital mortality was 39% for AD, 34% for ruptured AAA, and 41% for ruptured TAA. Hypertension
was present in 86% of individuals who subsequently developed AD, was strongly associated with incident AD (hazard ratio [HR]
2.64, 95% CI 1.33 to 5.25), and conferred a population-attributable risk of 54%. Hypertension was also a risk factor for AAA with a
smaller effect. Smoking (HR 5.07, 95% CI 3.52 to 7.29) and high apolipoprotein B/A1 ratio (HR 2.48, 95% CI 1.73 to 3.54) were
strongly associated with AAA and conferred a population-attributable risk of 47% and 25%, respectively. Smoking was also a risk
factor for AD and TAA with smaller effects.
Conclusions-—This large prospective study identiﬁed distinct risk factor proﬁles for different aortic diseases in the general
population. Hypertension accounted for more than half of the population risk for AD, and smoking for half of the population risk
of AAA. ( J Am Heart Assoc. 2015;4:e001513 doi: 10.1161/JAHA.114.001513)
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R upture and dissection of the aorta are critical vascularevents that can cause severe internal hemorrhage and
have an acute mortality exceeding 20% even with modern
treatment.1 Such acute events can be prevented by surgical
or endovascular treatment, and potentially by timely risk
factor intervention, in individuals with aortic wall weakening
and dilation found on radiological or ultrasound imaging
examination. Reports of increasing incidence of aortic rupture,
dissection, and surgical treatment of aortic dilation in the
second half of the 20th century therefore motivated commu-
nity screening programs to identify individuals with dilation of
the abdominal aorta who might beneﬁt from surgical or
endovascular interventions. However, the initial results of
such screening programs in broad age- and sex-speciﬁc
groups have recently been reported, with lower prevalence
estimates of aortic dilation than expected observed in several
countries.2–5 These ﬁndings have led to calls for improved
cost-effectiveness in screening programs by focusing on high-
risk populations.2,3 We were therefore interested in evaluating
the population risk for aortic disease attributable to each of
the major cardiovascular risk factors.
Gradual aortic dilation precedes the development of aortic
aneurysms and, to some extent, aortic dissection (AD).
However, in the International Registry of Acute Aortic
Dissection (IRAD) >80% of ADs developed in the absence of
a preexisting aneurysm, indicating that ruptured aneurysms
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and dissection represent distinct pathophysiological states.6,7
Furthermore, different mechanisms are thought to drive aortic
dilation and rupture at different aortic sites, most importantly
for abdominal compared with thoracic aortic aneurysms
(AAAs and TAAs, respectively).8 It can therefore be hypoth-
esized that risk proﬁles differ between these diseases.
Previous studies of risk factors for aortic disease are, with
a few exceptions, limited in interpretation by case series
design such as the IRAD, by case-control designs, or by
focusing on cross-sectional risk factor associations with aortic
diameter rather than clinical outcomes.9–16 Accurate inci-
dence and population-attributable risks (PARs) cannot be
estimated from such study designs. We therefore used a large
Swedish population-based cohort study of middle-aged sub-
jects with long-term follow-up to evaluate the population risk
attributable to major risk factors for AD and severe
aneurysms in the abdominal (AAA) or thoracic aorta (TAA),
deﬁned as ruptured or surgically treated aneurysms.
Methods
Study Sample
The population-based Malm€o Diet and Cancer Study (MDCS)
includes 30 447 men born 1923–1945 and women born in
1923–1950 from the general population of Malm€o, Sweden.
Participants attended baseline examinations between 1991
and 1996 with sampling of peripheral venous blood and
ascertainment of clinical characteristics as previously
described.17 Participants underwent anthropometric measure-
ments and blood pressure measurement using a mercury-
column sphygmomanometer in the supine position after
10 minutes of rest, and they completed a questionnaire that
included questions about smoking and medication use.
Apolipoproteins A1 (apoA1) and B (apoB) were measured at
Quest Diagnostics (San Juan Capistrano, CA), blinded to case-
control status, by using an immunonephelometric assay run
on the Siemens BNII. The interassay variability was <4.0% for
both apoA1 and apoB. Traditional low-density lipoprotein
(LDL) and high-density lipoprotein (HDL) cholesterol fractions
were available in a random subset of 5444 patients.18 The
Pearson correlation coefﬁcients between apolipoproteins and
the corresponding traditional cholesterol fractions were 0.72
(apoA1-HDL), 0.73 (apoB-LDL), and 0.86 (apoB/apoA1-LDL/
HDL). Smoking was deﬁned as self-reported regular smoking
or smoking cessation within the past year. Hypertension was
deﬁned as use of antihypertensive medication or blood
pressure ≥140/90 mm Hg. Obesity was deﬁned as body
mass index (BMI) >30 kg/m2. Diabetes mellitus was deﬁned
as a (1) self-reported physician’s diagnosis or use of
antidiabetic medications or from 1 of 5 nationwide or regional
registers―a diagnosis of diabetes in the nationwide Swedish
Diabetes Register, the nationwide Inpatient Register with
coverage of all hospital discharges and outpatient care at
Swedish hospitals, the regional Diabetes 2000 register of the
Scania region in southern Sweden in which Malm€o is the
largest city, or (2) a prescription of antidiabetic medication in
the nationwide Swedish Prescribed Drug Register, or (3) if at
least 2 glycated hemoglobin recordings were ≥6.0% according
to the Swedish Mono-S standardization system (correspond-
ing to 7.0% according to the US National Glycohemoglobin
Standardization Program [NGSP]) in the Malm€o HbA1c
register, which includes all glycated hemoglobin samples
measured since 1988 at the Department of Clinical Chemis-
try, which receives samples from the entire greater Malm€o
area. Informed consent was obtained from all participants,
and the study was approved by the ethics committee of Lund
University, Sweden.
End Point Ascertainment and Validation
Individuals from the MDCS with a ﬁrst registered diagnosis of
AD, AAA, TAA, ruptured AAA, or ruptured TAA or who
underwent a surgical procedure for AAA or TAA were
identiﬁed from Swedish national registers (the Inpatient
Register and the Cause of Death Register) by linkage of the
10-digit personal identiﬁcation number unique to each
Swedish resident.19 These registers have complete coverage
of Swedish hospitals through the tax-ﬁnanced health care
system, and reimbursement to hospital departments is
dependent on correct diagnostic coding. Both registers were
established in the 1950s–1960s and are administered by the
National Board of Health and Welfare (http://www.socialsty-
relsen.se/english).20,21 The Inpatient Register includes infor-
mation on dates of admission and discharge as well as
diagnostic and procedural codes from all hospitalizations in
Sweden. The Cause of Death Register includes diagnoses of
underlying and contributing causes of death from death
certiﬁcates. In both registers, diagnoses are coded using a
Swedish revision of the International Classiﬁcation of Disease
(ICD). The eighth edition (ICD-8) was used until the end of
1986, the ninth edition (ICD-9) was used between 1987 and
1996, and the 10th edition (ICD-10) has been used since
1997. Before 1997, the Swedish classiﬁcation Op6 was used
for surgical procedures, and since 1997, the KKA97 classi-
ﬁcation has been used, a Swedish revision of the Classiﬁca-
tion of Surgical Procedures from the Nordic Medico-Statistical
Committee (1996). End points were deﬁned from diagnosis
codes as shown in Table 1 and from codes for surgical
procedures as shown in Table 2. The acute mortality in
ruptured aneurysms and in AD, deﬁned as death before
reaching a hospital or during the ﬁrst admission, was
determined from the Inpatient Register and the Cause of
Death Register.
DOI: 10.1161/JAHA.114.001513 Journal of the American Heart Association 2
Risk Proﬁles for Aortic Diseases Landenhed et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
High validity of the diagnosis and surgical procedure codes
for AAA used in the present study have been described
previously in nationwide Swedish registers.20,22,23 We veriﬁed
all diagnoses or surgical procedures for AD and TAAs through
a review of patient records and radiological images. Informa-
tion on diagnostic modalities used was retrieved along with
information about the location of aortic disease. Diagnostic
deﬁnitions were in accordance with guideline recommenda-
tions.24 Patient records were also reviewed for individuals
with a procedural code indicating surgery for AAA but without
a diagnostic code to verify that the procedure was performed
for AAA.
Statistical Analysis
Individuals with a diagnosis of AAA, AD, or TAA at baseline
(n=35; 28 with AAA, 4 with TAA, 2 with AD, and 1 with both
AAA and TAA) or with missing information on risk factors were
excluded from the current study. For these exclusions, we
identiﬁed subjects with any occurrence of such diagnoses
rather than only ruptured or surgically treated cases. End
points studied in subsequent prospective analyses were
deﬁned as to reﬂect severe, clinically relevant disease and
included AD, AAA deﬁned as ruptured or surgically treated
AAA, and TAA deﬁned as ruptured or surgically treated TAA.
Risk factors for these 3 end points were assessed by using
Cox proportional hazards regression models. Each risk factor
was tested in age- and sex-adjusted models, and signiﬁcant
risk factors were included in a multivariable model. The
proportionality of hazards assumption was conﬁrmed through
visual inspection of log-negative log survival curves. Age- and
sex-standardized incidence rates were calculated as the
number of events per 100 000 person-years at risk, with CIs
calculated under the assumption of a Poisson distribution. The
PAR estimates were calculated for each risk factor by using
the standard formula,25 adjusting for age and sex by
stratiﬁcation as previously described.17,26 Analyses were
performed by using SAS 9.2 (SAS Institute).
Results
End Point Validation
Of 103 subjects with a diagnosis of TAA before or after
baseline and 81 with AD, patient records were retrieved for all
except 4 (4%) subjects with TAA and 10 (12%) with AD whose
records were unavailable as shown in Figures 1 and 2. The
diagnosis was conﬁrmed in 92 subjects with TAA and 63 with
AD, resulting in positive predictive values of 93% and 89% for
the corresponding diagnosis codes in national registers,
respectively. A majority of patients with AD (62%) and TAA
(88%) had radiological evidence of aortic disease. A large
proportion of AD cases (29%) and a smaller proportion of TAA
cases (5%) were diagnosed on autopsy. A smaller number
were diagnosed through echocardiography with TAA (n=5) or
AD (n=1), and 2 individuals with TAA and 5 with AD were
diagnosed via visual inspection during surgery. Intramural
hematoma on computed tomography (n=1) was considered
equivalent to AD.
Individuals determined to be miscoded most commonly
had aneurysms without evidence of dissection but were
miscoded as such (n=5), vice versa (n=2), or had AAAs
without evidence of thoracic aortic involvement but were
miscoded as such (n=3), highlighting some level of confusion
in the medical community about differentiating aortic dis-
eases. The remainder of miscoded diagnoses stemmed from
clinical suspicion at time points when patients were trans-
ferred across medical units before completion of diagnostic
examinations.
Baseline Characteristics
In all analyses in the current study, we elected to use strict
criteria for severe and clinically relevant aneurysms, deﬁned
as ruptured or surgically treated aneurysms. For AD, all
diagnosed cases were included. During up to 20 years of
follow-up (median 16 years, IQR 14.8 to 17.7 years), the
incidence rate per 100 000 patient-years at risk was 27 (95%
Table 1. Diagnosis Codes for Aortic Disease
ICD-8 ICD-9 ICD-10
AAA 441.2 441D, 441E I713, I714, I715, I716
Ruptured AAA 441D 441D I713, I715
AD 441.0 441A I710
TAA 441.1 441B, 441C I711, I712, I715, I716
Ruptured TAA 441B 441B I711. I715
ICD indicates International Classiﬁcation of Disease; AAA, abdominal aortic aneurysm;
AD, aortic dissection; TAA, thoracic aortic aneurysm.
Table 2. Codes for Surgical Procedures for Aortic Disease
Op6 KKA97
AAA 8807, 8808, 0961, 0962 PCG10, PCQ10, PDG (all subcodes
except PDG30), PDN10, PDP10,
PDQ10, PDQ21
TAA 3131, 3139, 3145, 3146 FCA, FCB, FCC, FCD, FDH (all
subcodes except FCA83, FCA84,
FCB80, FCB82, FCC80, FCC82,
FCD80, FCD82), FCE00, FCW96
AAA indicates abdominal aortic aneurysm; TAA, thoracic aortic aneurysm.
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CI 22.5 to 32.1) for ruptured or surgically treated aneurysms
in the abdominal aorta, 9 (95% CI 6.8 to 12.6) for aneurysms
in the thoracic aorta, and 15 (95% CI 11.7 to 18.9) for AD, as
outlined in Figure 3. The total cumulative incidence of aortic
disease was 0.8% in the MDCS cohort. Of individuals with TAA
and AAA, 36.2% and 60.2% of subjects ﬁrst presented with a
ruptured aneurysm, respectively. The acute mortality, deﬁned
as death before reaching a hospital or during the ﬁrst
Diagnosis code 
of TAA 
(n=103)
Diagnosis
confirmed
93% (n=92)
Diagnosis not 
confirmed 7% 
(n=7)
Records 
unavailable 
(n=4)
Miscoded AD
(n=2)
Miscoded AAA
(n=3)
Suspected 
diagnosis 
(n=2)
Radiology
(n=81)
Echocardio-
graphy 
(n=5)
Autopsy
(n=4)
Surgery
(n=2)
Figure 2. Validation of thoracic aortic aneurysms (TAAs). AAA indicates abdominal aortic aneurysm; AD, aortic dissection.
Diagnosis code 
of AD 
(n=81)
Diagnosis confirmed 
89% (n=63)
Diagnosis not 
confirmed 
11% (n=8)
Records unavailable 
(n=10)
Miscoded TAA
(n=5)
Suspected diagnosis 
(n=3)
Radiology
(n=39)
Echocardiography 
(n=1)
Autopsy
(n=18)
Surgery
(n=5)
Figure 1. Validation of aortic dissections. AD indicates aortic dissection; TAA, thoracic aortic aneurysm.
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admission, was 39% for AD, 41% for ruptured TAA, and 34% for
ruptured AAA. Baseline characteristics for the MDCS cohort
and subjects with aortic diseases are shown in Table 3.
Abdominal Aortic Aneurysm
Increasing age and male compared with female sex were
strongly associated with increased risk of incident ruptured or
surgically treated AAAs (P<0.05). In age- and sex-adjusted
models, hypertension, smoking, apoA1, apoB, and apoB/
apoA1 were also strongly associated with incident AAA as
shown in Table 4. The incidence rate of AAA per 100 000
person-years at risk was 58 (95% CI 46.1 to 73.0) in smokers
and 15 (95% CI 10.8 to 19.3) in nonsmokers as shown in
Table 5. Diabetes and obesity were inversely but nonsignif-
icantly associated with AAA. In multivariable analyses
incorporating age, sex, smoking, hypertension, apoA1, and
apoB, all remained signiﬁcantly associated with incident AAA
although only nominally for apoB (P=0.05) as shown in
Table 6. The proportions of AAA risk attributable to hyper-
tension, smoking, and high apoB/apoA1 were 34%, 47%, and
25%, respectively.
Thoracic Aortic Aneurysm
A majority of ruptured or surgically treated TAAs (80%)
affected the ascending aorta as shown in Table 3. Increasing
age and male sex were associated with increased risk of
incident TAA (P<0.05). In age- and sex- adjusted models, only
smoking was signiﬁcantly associated with incident TAA as
shown in Table 4, although a trend to increased risk was
observed for high apoB (P=0.09). The proportion of TAA risk
attributable to smoking was 19%. Diabetes and obesity were
nonsigniﬁcantly inversely associated with TAA.
Aortic Dissection
A majority of dissections were classiﬁed as Stanford type A
(58% of individuals with information on subtype), similar to
observations in the IRAD (62%).1 Increasing age and male sex
were associated with increased risk of incident AD (P<0.05).
In age- and sex-adjusted models, hypertension, smoking, and
apoA1 were signiﬁcantly associated with AD. The incidence of
AD per 100 000 patient-years at risk was 21 (95% CI 16.3 to
27.5) in individuals with hypertension and 5 (95% CI 2.6 to
9.8) in normotensive individuals. Diabetes and obesity were
not associated with incident AD (P>0.05). The proportions of
AD risk attributable to hypertension, smoking, and low apoA1
were 54%, 14%, and 30%, respectively. In multivariable models
incorporating age, sex, hypertension, smoking, and apoA1, all
remained signiﬁcantly associated with incident AD as shown
in Table 6.
Discussion
Using a large population-based cohort of middle-aged indi-
viduals with follow-up from nationwide Swedish registers, we
prospectively evaluated the incidence and mortality of
different aortic diseases, assessed risk factors, and the
population risk of aortic diseases attributable to risk factors.
Our results conﬁrmed high acute mortality in acute dissection
and rupture, 34% to 41%, and identiﬁed hypertension and
smoking as predominant risk factors for AD and AAA,
respectively, explaining 54% and 47% of population risk.
Smoking was also associated with AD and TAA, and
apolipoprotein concentrations with AD and AAA, although
with smaller contributions to population risk. Overall, our
ﬁndings add to a small number of previous prospective
studies for aortic disease9–16 and provide support for distinct
Malmö Diet and Cancer
(n=30 412)
Incident AAA
(n=127)
27 / 100 000 PYAR
Incident AD
(n=70)
15 / 100 000 PYAR
Incident TAA
(n=45)
10 / 100 000 PYAR
Malmö Diet and Cancer study
(n=30 447)
Prevalent 
AAA
(n=29)*
Prevalent 
TAA
(n=5)*
Prevalent 
AD
(n=2)
Figure 3. Description of Malm€o Diet and Cancer Study (MDCS)
cohort with incident aortic dissection (AD) and ruptured or
surgically treated aneurysms. Subjects in the MDCS cohort with
a diagnosis of aortic disease before baseline who were excluded
from the present study and subjects who were diagnosed with
incident AD or ruptured or surgically treated aneurysms in the
abdominal (AAA) or thoracic (TAA) aorta during up to 20 years of
follow-up. PYAR indicates person-years at risk. *One patient was
diagnosed with both AAA and TAA before baseline.
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risk proﬁles for different aortic diseases, with hypertension
accounting for more than half of AD risk, smoking for half of
AAA risk, and a more complex risk proﬁle present for TAA.
Hypertension and AD
Hypertension is often considered the most important risk
factor for AD, with reference to the IRAD study, in which 80%
of AD cases were diagnosed with hypertension.1,6,10 However,
only 1 previous prospective study of AD has been reported,
comprising the population from Oxfordshire, England.16,27
That recent study and the current prospective study consis-
tently observed hypertension to be the most important risk
factor. In the current study, hypertension was present in 86%
of individuals who subsequently developed AD during follow-
up. More important, hypertension at baseline translated into a
PAR of 54% for AD, with an incidence rate of 21 per 100 000
person-years at risk in hypertensive individuals compared with
5 in normotensive individuals. Our study in combination with
the study from Oxfordshire provides strong support for the
contention that half of AD events could be prevented by
pharmacological intervention in hypertensive subjects, similar
to what has been shown in randomized controlled trials for
stroke, heart failure, myocardial infarction, renal failure, and
mortality.28,29 Whether targeted interventions for aortic
outcomes with speciﬁc therapeutic alternatives such as
inhibitors of the renin-angiotensin-aldosterone system or b-
blockers could be useful remains to be seen.29
Smoking and AAAs
Smoking has been reported to be the major risk factor for
AAAs in several studies of both prospective and case-control
design.9,12–15 Our results conﬁrm these ﬁndings in a large
prospective cohort with long-term follow-up and a strict,
validated end point. Smoking contributed 47% of population
risk for rupture or surgically treated AAA, and the incidence
rate of AAA was 58 per 100 000 person-years at risk
Table 3. Baseline Characteristics in the Entire Cohort and Individuals With Incident Aortic Diseases
Characteristic MDCS (N=30 447) AAA (n=127) AD (n=70) TAA (n=45)
Baseline age, y 58.0 (7.6) 62.1 (5.9) 62.3 (6.7) 60.9 (6.6)
Male 12 067 (39.6%) 96 (75.6%) 46 (65.7%) 32 (71.1%)
Body mass index, kg/m2 25.8 (4.0) 25.7 (3.7) 26.5 (3.8) 26.9 (3.3)
Obesity 4245 (13.9%) 15 (11.8%) 10 (14.3%) 5 (11.1%)
Hypertension 18 574 (61.0%) 105 (82.7%) 60 (85.7%) 34 (75.6%)
Diabetes 1300 (4.3%) 5 (3.9%) 3 (4.3%) 2 (4.4%)
Smoking, current 8818 (29.0%) 77 (60.6%) 27 (38.6%) 19 (42.2%)
apoA1, mg/dL 156.8 (28.2) 139.8 (24.1) 144.4 (24.3) 149.3 (25.7)
apoB, mg/dL 107.2 (26.1) 116.8 (22.2) 107.0 (24.6) 113.6 (22.4)
apoB/apoA1 0.71 (0.22) 0.86 (0.22) 0.76 (0.20) 0.78 (0.20)
Age at diagnosis, y — 71.6 (6.5) 70.6 (6.4) 71.3 (6.0)
Location*
Ascending aorta — — — 36 (80.0%)
Aortic arch — — — 12 (26.7%)
Descending aorta — — — 16 (35.6%)
Stanford type
A — — 36 (58.1%) —
B — — 26 (41.9%) —
Unknown — — 8 —
Acute mortality, % — 34 39 41
Baseline characteristics for the entire Malm€o Diet and Cancer Study (MDCS) and individuals with incident aortic dissection (AD) or rupture or surgical treatment of aneurysms in the
abdominal (AAA) or thoracic aorta (TAA). Quantitative variables are presented as mean with SD. Dichotomous variables are presented as count and proportion. Location of thoracic
aneurysms (n=45) and dissection type (n=62) were determined from review of patient records where available. Percentages for Stanford type refers to individuals with information
available. Acute mortality was deﬁned as death before reaching a hospital or during the ﬁrst admission, and refers to individuals with AD or a ruptured aneurysm. apoA1 indicates
apolipoprotein A1.
apoB indicates apolipoprotein B.
*Occurrence of aneurysm in >1 location in several subjects.
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compared with 15 in nonsmokers. No prospective studies
have examined the impact of smoking cessation on incidence
of AAA, but reduced progression rate of AAAs with smoking
cessation has been reported.30 Together with such studies,
our results indicate large gains with smoking cessation and
that targeted screening for AAAs in smokers might constitute
a cost-effective alternative to community screening, as has
recently been proposed in European and US guidelines.31,32
Other Risk Factors and Aortic Disease
Smoking was a risk factor across the entire range of aortic
diseases, although with different risk magnitudes for different
diseases. Hypertension and dyslipidemia were also risk
factors for AD and AAA but were not signiﬁcantly associated
with the less common outcome TAA. In addition to more
limited statistical power to detect associations with TAA, we
suggest that this outcome might be more etiologically
heterogeneous, often occurring concomitant with connective
tissue diseases such as bicuspid aortic valve disease, or
Marfan syndrome.33 Dyslipidemia has not previously been
prospectively studied for association with AD. Our results
particularly implicate low apoA1 as a risk factor for AD.
Additional studies are needed to validate this observation and
clarify underlying mechanisms. The apoA1/apoB ratio was
most strongly associated with AAA, consistent with ﬁndings
for coronary disease.34 Previous studies have suggested
apolipoproteins to be slightly more sensitive markers of
cardiovascular risk than the traditional lipoprotein fractions
LDL and HDL.34,35 We observed strong correlation of
apolipoproteins with the corresponding traditional lipoprotein
fractions (correlation coefﬁcient >0.7) in the random subset
where both were available. We did not observe signiﬁcant
association of diabetes and obesity with any aortic disease.
Previous studies have surprisingly found lower rates of
aneurysmal disease and dissections in diabetic patients,9,11,36
and experimental studies have suggested mechanisms with
hyperglycemia such as increased stability of collagen
Table 4. Risk Factors and Population-Attributable Risk for Aortic Diseases
Risk Factor
AAA (n=127) AD (n=70) TAA (n=45)
HR (95% CI) P Value PAR HR (95% CI) P Value PAR HR (95% CI) P Value PAR
Hypertension 2.03 (1.27 to 3.26) 0.003 34% 2.64 (1.33 to 5.25) 0.006 54% 1.46 (0.73 to 2.95) 0.29 —
Smoking 5.07 (3.52 to 7.29) P<0.0001 47% 1.96 (1.21 to 3.20) 0.007 14% 2.20 (1.20 to 4.01) 0.01 19%
Diabetes 0.76 (0.31 to 1.87) 0.55 — 0.83 (0.26 to 2.66) 0.76 — 0.92 (0.22 to 3.82) 0.91 —
Obesity 0.85 (0.50 to 1.46) 0.56 — 1.02 (0.52 to 2.00) 0.95 — 0.80 (0.31 to 2.02) 0.63 —
apoB/apoA1 2.48 (1.73 to 3.54) P<0.0001 25% 0.86 (0.48 to 1.55) 0.62 — 1.22 (0.63 to 2.39) 0.55 —
apoA1 1.95 (1.36 to 2.79) P<0.0001 26% 1.97 (1.21 to 3.21) 0.006 30% 1.33 (0.72 to 2.47) 0.37 —
apoB 1.59 (1.08 to 2.33) 0.02 8% 0.79 (0.43 to 1.48) 0.47 — 1.73 (0.92 to 3.25) 0.09 —
Age- and sex-adjusted risk estimates for each risk factor with corresponding P-values and population-attributable risk (PAR). Risk estimates for apolipoproteins are based on individuals in
the highest quintile of the distribution for apoB (≥128 mg/dL) and apoB/apoA1 (≥0.88) and lowest quintile for apoA1 (≤133 mg/dL). AAA indicates aneurysms in the abdominal aorta;
AD, aortic dissection; apoA1, apolipoprotein A1; apoB, apolipoprotein B; TAA, thoracic aortic aneurysm.
Table 5. Incidence of Aortic Diseases Across Risk Groups
Risk Factor
AAA AD TAA
Unexposed Exposed Unexposed Exposed Unexposed Exposed
Hypertension 11.8 (7.4 to 17.8) 37.1 (30.3 to 45.0) 5.4 (2.6 to 9.8) 21.4 (16.3 to 27.5) 5.9 (2.9 to 10.5) 11.8 (8.1 to 16.5)
Smoking 14.6 (10.8 to 19.3) 58.4 (46.1 to 73.0) 12.8 (9.3 to 17.3) 20.4 (13.5 to 29.7) 7.5 (4.8 to 11.0) 14.4 (8.7 to 22.5)
Diabetes 27.0 (22.4 to 32.2) 27.9 (9.0 to 65.0) 14.9 (11.6 to 18.9) 16.7 (3.4 to 48.8) 9.4 (6.7 to 12.6) 11.1 (1.3 to 40.2)
Obesity 27.5 (22.6 to 33.1) 23.6 (13.2 to 39.0) 14.9 (11.3 to 19.1) 15.7 (7.5 to 29.0) 9.7 (6.9 to 13.2) 7.9 (2.6 to 18.4)
apoB/apoA1 18.8 (14.7 to 23.6) 65.2 (48.9 to 85.0) 14.6 (11.0 to 18.9) 16.9 (9.2 to 28.3) 8.3 (5.7 to 11.8) 14.5 (7.5 to 25.3)
apoA1 19.2 (14.8 to 24.4) 49.1 (37.5 to 63.2) 11.0 (7.8 to 15.1) 26.1 (17.9 to 36.9) 8.1 (5.4 to 11.7) 13.0 (7.5 to 21.2)
apoB 23.3 (18.7 to 28.7) 43.3 (30.5 to 59.7) 15.2 (11.5 to 19.7) 14.0 (7.2 to 24.5) 7.9 (5.3 to 11.2) 16.4 (8.9 to 27.5)
Age- and sex-standardized incidence rates per 100 000 person-years at risk in exposed compared with unexposed subjects, with 95% CIs. Incidence rates for apolipoproteins are based on
individuals in the highest quintile of the distribution for apoB (≥128 mg/dL) and lowest quintile for apoA1 (≤133 mg/dL). AAA indicates aneurysms in the abdominal aorta; AD, aortic
dissection; apoA1, apolipoprotein A1; apoB, apolipoprotein B; TAA, thoracic aortic aneurysm.
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cross-links and increased expression of plasminogen activator
inhibitor 1.37 The prevalence of diabetes was low in our study,
and therefore power to detect such associations was low.
However, the effect direction and magnitude were similar to
those of previous studies and were consistent with a
protective effect of diabetes on risk of aneurysm development
but not dissection.
Study Strengths and Limitations
The major strengths of the present study was the large size of
the population sample, which allowed prospective analyses
with an adequate number of aortic disease events to compute
incidence rates and study risk proﬁles relevant to the general
population. Many previous studies have been limited in
interpretation by case series or case-control designs or by
focusing on cross-sectional risk factor associations with aortic
diameter rather than clinical outcomes. Calls for prospective
studies of predictors have been raised, particularly for
incident AD and TAA, which have not been well studied,6 as
they are free of many of the biases inherent to case series and
case-control studies but are hampered by the need for large
cohort studies.38,39 The use of a prospective study design
with nationwide registers allowed capture of both fatal cases
from mortality registers and hospitalized cases from dis-
charge registers. The registers used here have complete
coverage of hospitals in the tax-ﬁnanced nationwide health
care system, and reimbursement to hospital departments is
dependent on correct diagnostic coding. Furthermore, in
contrast to several previous studies of aortic disease, each
event of AD and TAA was conﬁrmed by review of individual
patient records. The high validity observed in national
registers for broadly deﬁned diagnoses of AD and TAA in
the present study lends additional credibility to ﬁndings from
previous register-based studies of these diseases that have
also used physician’s ICD coding as outcome variables but not
adjudicated end points.11,40 In risk factor analyses, we
focused on clinically relevant end points including subjects
diagnosed with incident AD, aneurysmal rupture, or surgical
intervention for AAAs, rather than all subjects diagnosed with
aortic dilation.
However, our study also has limitations that merit consid-
eration. First, subjects were followed for as long as 20 years
without reassessment of risk factor burden. It is likely that the
risk factor status may have changed in some individuals during
that time, which would be expected to attenuate the effect of
risk factors, termed “regression dilution,” potentially resulting
in underestimates of risk factor contributions to population
risk. Second, our study design did not allow investigation of the
contribution of less common risk factors for aortic disease,
such as connective tissue diseases and aortic valvular disease,
of which the most common, Marfan syndrome and bicuspid
aortic valve, have been reported in 3% to 6% and in less than 2%
to 4% of AD patients, respectively.6 Although such conditions
might explain a sizeable proportion of AD cases diagnosed
before 40 years of age,41 the contribution of these conditions
to the overall aortic disease burden in the general population is
likely to be limited, possibly with the exception of TAA.
Additional studies with careful clinical characterization would
be required to prospectively study the collective contribution
of such less common disease entities.
Conclusion
Our results establish distinct clinical risk factor proﬁles for
critical aortic diseases. Hypertension accounts for more than
half of the population risk for AD, while smoking accounts for
half of population risk for severe aneurysms in the abdominal
Table 6. Risk Factors for Aortic Diseases in Multivariable-Adjusted Analyses
Risk Factor
AAA (n=127) AD (n=70) TAA (n=45)
HR (95% CI) P Value HR (95% CI) P Value HR (95% CI) P Value
Age 2.55 (1.93 to 3.36) <0.0001 2.30 (1.57 to 3.36) <0.0001 2.05 (1.34 to 3.14) 0.001
Sex 3.41 (2.17 to 5.36) <0.0001 1.84 (1.05 to 3.23) 0.03 3.66 (1.92 to 6.98) <0.0001
Smoking 5.13 (3.49 to 7.54) <0.0001 1.91 (1.12 to 3.25) 0.02 2.20 (1.20 to 4.01) 0.01
Hypertension 2.21 (1.35 to 3.62) 0.002 3.37 (1.51 to 7.55) 0.003 — —
Diabetes — — — — — —
Obesity — — — — — —
apoA1 0.85 (0.78 to 0.92) <0.0001 0.87 (0.78 to 0.97) 0.01 — —
apoB 1.07 (1.00 to 1.15) 0.05 — — — —
Risk estimates for each risk factor from Cox proportional hazards regression models including all signiﬁcant risk factors from age- and sex-adjusted models. Risk estimates for age are
presented per 10 years and for apolipoproteins per 10 mg/dL. AAA indicates aneurysms in the abdominal aorta; AD, aortic dissection; apoA1, apolipoprotein A1; apoB, apolipoprotein B;
TAA, thoracic aortic aneurysm.
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aorta. Our ﬁndings have important implications for the
targeted surveillance and prevention of aortic disease,
suggesting that preventive interventions targeting the popu-
lation burden of AD should focus on hypertension, whereas
AAA interventions should focus on smokers.
Acknowledgments
The authors wish to thank all participants in the MDCS for making
this study possible.
Sources of Funding
The MDCS was made possible by grants from the Swedish
Cancer Society, the Swedish Medical Research Council, the
Swedish Dairy Association, the Albert Pahlsson and Gunnar
Nilsson Foundations, and the Malm€o City Council. Dr
Gotts€ater was supported by the Hulda Almroths Research
Foundation. Drs Gotts€ater and Melander were supported by
Skane University Hospital in Malm€o and the Ernhold Lun-
dstr€oms Research Foundation. Drs Hedblad and Melander
were supported by the Swedish Medical Research Council. Dr
Newton-Cheh was supported by grants from the US National
Institutes of Health (HL080025, HL098283) and the Burr-
oughs Wellcome Fund. Dr Melander was supported by grants
from the Medical Faculty of Lund University, the Albert
Pahlsson Research Foundation, the Crafoord Foundation, the
Swedish National Health Service, the Hulda and Conrad
Mossfelt Foundation, the King Gustaf V and Queen Victoria
Fund, the Lennart Hanssons Memorial Fund, the Marianne and
Marcus Wallenberg Foundation, and the Knut and Alice
Wallenberg Foundation. Dr Smith was supported by the
Swedish Heart-Lung Foundation, the Swedish Research
Council, the Crafoord Foundation, the Swedish National
Health Service, and Skane University Hospital in Lund.
Measurement of apolipoproteins was performed and sup-
ported by Quest Diagnostics. The funding sources had no role
in the study design; in the collection, analysis, and interpre-
tation of data; in the writing of the report; or in the decision to
submit the manuscript for publication.
Disclosures
Measurement of apolipoproteins was performed and sup-
ported by Quest Diagnostics, where the coauthor Dr Caulﬁeld
is an employee and was responsible for laboratory measure-
ments, blinded to the outcomes of the study.
References
1. Hagan PG, Nienaber CA, Isselbacher EM, Bruckman D, Karavite DJ, Russman
PL, Evangelista A, Fattori R, Suzuki T, Oh JK, Moore AG, Malouf JF, Pape LA,
Gaca C, Sechtem U, Lenferink S, Deutsch HJ, Diedrichs H, Marcos y Robles J,
Llovet A, Gilon D, Das SK, Armstrong WF, Deeb GM, Eagle KA. The
International Registry of acute Aortic Dissection (IRAD): new insights into an
old disease. JAMA. 2000;283:897–903.
2. Lederle FA. The rise and fall of abdominal aortic aneurysm. Circulation.
2011;124:1097–1099.
3. Svensjo S, Bjorck M, Gurtelschmid M, Djavani Gidlund K, Hellberg A,
Wanhainen A. Low prevalence of abdominal aortic aneurysm among 65-year-
old Swedish men indicates a change in the epidemiology of the disease.
Circulation. 2011;124:1118–1123.
4. Conway AM, Malkawi AH, Hinchliffe RJ, Holt PJ, Murray S, Thompson MM,
Loftus IM. First-year results of a national abdominal aortic aneurysm screening
programme in a single centre. Br J Surg. 2012;99:73–77.
5. Earnshaw JJ. Doubts and dilemmas over abdominal aortic aneurysm. Br J Surg.
2011;98:607–608.
6. Golledge J, Eagle KA. Acute aortic dissection. Lancet. 2008;372:55–66.
7. Pape LA, Tsai TT, Isselbacher EM, Oh JK, O’Gara PT, Evangelista A, Fattori R,
Meinhardt G, Trimarchi S, Bossone E, Suzuki T, Cooper JV, Froehlich JB,
Nienaber CA, Eagle KA. Aortic diameter >or = 5.5 cm is not a good predictor
of type A aortic dissection: observations from the International Registry of
acute Aortic Dissection (IRAD). Circulation. 2007;116:1120–1127.
8. Norman PE, Powell JT. Site speciﬁcity of aneurysmal disease. Circulation.
2010;121:560–568.
9. Nordon IM, Hinchliffe RJ, Loftus IM, Thompson MM. Pathophysiology and
epidemiology of abdominal aortic aneurysms. Nat Rev Cardiol. 2011;8:92–
102.
10. LeMaire SA, Russell L. Epidemiology of thoracic aortic dissection. Nat Rev
Cardiol. 2011;8:103–113.
11. Prakash SK, Pedroza C, Khalil YA, Milewicz DM. Diabetes and reduced risk for
thoracic aortic aneurysms and dissections: a nationwide case-control study. J
Am Heart Assoc. 2012;1:jah3-e000323 doi: 10.1161/JAHA.111.000323.
12. Iribarren C, Darbinian JA, Go AS, Fireman BH, Lee CD, Grey DP. Traditional and
novel risk factors for clinically diagnosed abdominal aortic aneurysm: the
Kaiser multiphasic health checkup cohort study. Ann Epidemiol. 2007;17:669–
678.
13. Alcorn HG, Wolfson SK Jr, Sutton-Tyrrell K, Kuller LH, O’Leary D. Risk factors
for abdominal aortic aneurysms in older adults enrolled in the Cardiovascular
Health Study. Arterioscler Thromb Vasc Biol. 1996;16:963–970.
14. Rodin MB, Daviglus ML, Wong GC, Liu K, Garside DB, Greenland P, Stamler J.
Middle age cardiovascular risk factors and abdominal aortic aneurysm in older
age. Hypertension. 2003;42:61–68.
15. Forsdahl SH, Singh K, Solberg S, Jacobsen BK. Risk factors for abdominal
aortic aneurysms: a 7-year prospective study: the Tromsø Study, 1994–2001.
Circulation. 2009;119:2202–2208.
16. Howard DP, Banerjee A, Fairhead JF, Perkins J, Silver LE, Rothwell PM.
Population-based study of incidence and outcome of acute aortic dissection
and premorbid risk factor control: 10-year results from the Oxford Vascular
Study. Circulation. 2013;127:2031–2037.
17. Smith JG, Platonov PG, Hedblad B, Engstrom G, Melander O. Atrial ﬁbrillation in
the Malmo Diet and Cancer Study: a study of occurrence, risk factors and
diagnostic validity. Eur J Epidemiol. 2010;25:95–102.
18. Smith JG, Newton-Cheh C, Almgren P, Struck J, Morgenthaler NG, Bergmann A,
Platonov PG, Hedblad B, Engstr€om G, Wang TJ, Melander O. Assessment of
conventional cardiovascular risk factors and multiple biomarkers for the
prediction of incident heart failure and atrial ﬁbrillation. J Am Coll Cardiol.
2010;56:1712–1719.
19. Ludvigsson JD, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish
personal identity number: possibilities and pitfalls in healthcare and medical
research. Eur J Epidemiol. 2009;24:659–667.
20. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C,
Heurgren M, Otterblad Olausson P. External review and validation of the
Swedish national inpatient register. BMC Public Health. 2011;11:450.
21. Johansson LA, Westerling R. Comparing Swedish hospital discharge records
with death certiﬁcates: implications for mortality statistics. Int J Epidemiol.
2000;29:495–502.
22. Acosta S, Ogren M, Bengtsson H, Bergqvist D, Lindblad B, Zdanowski Z.
Increasing incidence of ruptured abdominal aortic aneurysm: a population-
based study. J Vasc Surg. 2006;44:237–243.
23. Troeng T, Malmstedt J, Bjorck M. External validation of the Swedvasc registry:
a ﬁrst-time individual cross-matching with the unique personal identity
number. Eur J Vasc Endovasc Surg. 2008;36:705–712.
24. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, Eagle KA,
Hermann LK, Isselbacher EM, Kazerooni EA, Kouchoukos NT, Lytle BW,
Milewicz DM, Reich DL, Sen S, Shinn JA, Svensson LG, Williams DM. 2010
ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the
DOI: 10.1161/JAHA.114.001513 Journal of the American Heart Association 9
Risk Proﬁles for Aortic Diseases Landenhed et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
diagnosis and management of patients with thoracic aortic disease. Circula-
tion. 2010;121:e266–e369.
25. Levin ML. The occurrence of lung cancer in man. Acta Unio Int Contra
Cancrum. 1953;9:531–541.
26. Walter SD. The estimation and interpretation of attributable risk in health
research. Biometrics. 1976;32:829–849.
27. Howard DP, Sideso E, Handa A, Rothwell PM. Incidence, risk factors, outcome
and projected future burden of acute aortic dissection. Ann Cardiothorac Surg.
2014;3:278–284.
28. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G,
Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L,
Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti A, Vahanian A,
Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano
C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera
M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E,
Ambrosioni E, Lindholm LH, Manolis A, Nilsson PM, Redon J, Struijker-
Boudier HA, Viigimaa M, Adamopoulos S, Bertomeu V, Clement D, Farsang
C, Gaita D, Lip G, Mallion JM, Manolis AJ, O’Brien E, Ponikowski P,
Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B. 2007
Guidelines for the management of arterial hypertension: the task force for
the management of arterial hypertension of the European Society of
Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur
Heart J. 2007;28:1462–1536.
29. Golledge J, Norman PE. Current status of medical management for abdominal
aortic aneurysm. Atherosclerosis. 2011;217:57–63.
30. Brady AR, Thompson SG, Fowkes FG, Greenhalgh RM, Powell JT. Abdominal
aortic aneurysm expansion: risk factors and time intervals for surveillance.
Circulation. 2004;110:16–21.
31. Moll FL, Powell JT, Fraedrich G, Verzini F, Haulon S, Waltham M, van
Herwaarden JA, Holt PJ, van Keulen JW, Rantner B, Schlosser FJ, Setacci F,
Ricco JB. Management of abdominal aortic aneurysms clinical practice
guidelines of the European society for vascular surgery. Eur J Vasc Endovasc
Surg. 2011;41(suppl 1):S1–S58.
32. Screening for abdominal aortic aneurysm: recommendation statement. Ann
Intern Med. 2005;142:198–202.
33. El-Hamamsy I, Yacoub MH. Cellular and molecular mechanisms of thoracic
aortic aneurysms. Nat Rev Cardiol. 2009;6:771–786.
34. McQueen MJ, Hawken S, Wang X, Ounpuu S, Sniderman A, Probstﬁeld J, Steyn
K, Sanderson JE, Hasani M, Volkova E, Kazmi K, Yusuf S; INTERHEART study
investigators. Lipids, lipoproteins, and apolipoproteins as risk markers of
myocardial infarction in 52 countries (the INTERHEART study): a case-control
study. Lancet. 2008;372:224–233.
35. Emerging Risk Factors Collaboration, Di Angelantonio E, Gao P, Pennells L,
Kaptoge S, Caslake M, Thompson A, Butterworth AS, Sarwar N, Wormser D,
Saleheen D, Ballantyne CM, Psaty BM, Sundstr€om J, Ridker PM, Nagel D,
Gillum RF, Ford I, Ducimetiere P, Kiechl S, Koenig W, Dullaart RP, Assmann G,
D’Agostino RB Sr, Dagenais GR, Cooper JA, Kromhout D, Onat A, Tipping RW,
Gomez-de-la-Camara A, Rosengren A, Sutherland SE, Gallacher J, Fowkes FG,
Casiglia E, Hofman A, Salomaa V, Barrett-Connor E, Clarke R, Brunner E,
Jukema JW, Simons LA, Sandhu M, Wareham NJ, Khaw KT, Kauhanen J,
Salonen JT, Howard WJ, Nordestgaard BG, Wood AM, Thompson SG, Boekholdt
SM, Sattar N, Packard C, Gudnason V, Danesh J. Lipid-related markers and
cardiovascular disease prediction. JAMA. 2012;307:2499–2506.
36. Tsai CL, Lin CL, Wu YY, Shieh DC, Sung FC, Kao CH. Advanced complicated
diabetes mellitus is associated with a reduced risk of thoracic and abdominal
aortic aneurysm rupture: a population-based cohort study. Diabetes Metab Res
Rev. 2014. Epub July 27.
37. Pasterkamp G. Methods of accelerated atherosclerosis in diabetic patients.
Heart. 2013;99:743–749.
38. Sackett DL. Bias in analytic research. J Chronic Dis. 1979;32:51–63.
39. Kopec JA, Esdaile JM. Bias in case-control studies. A review. J Epidemiol
Community Health. 1990;44:179–186.
40. Olsson C, Thelin S, Stahle E, Ekbom A, Granath F. Thoracic aortic aneurysm
and dissection: increasing prevalence and improved outcomes reported in a
nationwide population-based study of more than 14,000 cases from 1987 to
2002. Circulation. 2006;114:2611–2618.
41. Januzzi JL, Isselbacher EM, Fattori R, Cooper JV, Smith DE, Fang J, Eagle KA,
Mehta RH, Nienaber CA, Pape LA. Characterizing the young patient with aortic
dissection: results from the International Registry of Aortic Dissection (IRAD). J
Am Coll Cardiol. 2004;43:665–669.
DOI: 10.1161/JAHA.114.001513 Journal of the American Heart Association 10
Risk Proﬁles for Aortic Diseases Landenhed et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
